Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.68 | 16.34 |
PEG Ratio (TTM) | 0.76 | 0.09 |
P/S Ratio (TTM) | 2.66 | 4.12 |
P/B Ratio (TTM) | 1.07 | 3.04 |
P/FCF Ratio (TTM) | -3.93 | 16.02 |
Price to 5YR AVG Earnings Ratio | N/A | 39.91 |
Price to 5YR AVG FCF Ratio | N/A | 22.44 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -17.76% | 10.28% |
ROE (TTM) | -33.83% | 19.10% |
Net Profit Margin (TTM) | -69.35% | -43.56% |
ROIC 5YR AVG | N/A | 24.60% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -602.92% | -196.94% | N/A |
Revenue | 1.40% | 57.46% | N/A |
Net Income | -611.23% | -195.12% | N/A |
Cash Flow | -0.50% | 110.11% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.02 | 1.79 |
Quick Ratio (TTM) | 1.02 | 1.68 |
D/E Ratio (TTM) | 0.25 | 18.26 |
Interest Coverage (TTM) | -2.46 | 18.28 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | 0.75 | 2.92 |
LTL to 5YR AVG FCF | N/A | 18.05 |
Shares Outstanding Growth 5YR AVG | N/A | 16.73% |